N20 Program
Outline
See keynote speakers, panels and panelists shaping the 2026 Neuroscience20 Summit — alongside the working program, global panel architecture and organizations supporting the meeting.
The people shaping the N20 conversation.
The leadership directory is separated from the working schedule so visitors can understand who is leading the summit before moving into the program and panel architecture.
N20 Summit President
🇺🇸🇦🇺🇺🇸🇺🇸🇺🇸🇺🇸🇺🇸🇺🇸🇺🇸🇺🇸🇹🇷🇺🇸🇺🇸🇺🇸🇺🇸🇺🇸🇺🇸🇺🇸🇺🇸🇺🇸🇺🇸🇷🇺🇯🇵🇺🇸Babak Kateb MD, PhD
Full profile
N20 Summit Leadership
Kuldeep Singh Sidhu PhD
Full profile
N20 Summit Leadership
Vicky Yamamoto PhD
Full profile
N20 Summit Leadership
Stefano M. Sinicropi MD
Full profile
N20 Summit Leadership
Susan C. Pannullo MD, FAANS, FAAN, FCNS
Full profile
N20 Summit Leadership
Michael Y. Wang MD, MBA, FACS, FAANS
Full profile
Cross-sector panels built around the G20 health economy.
Panels bring together the categories specified for the Miami summit, creating a single interface for CEOs, public officials, scientists, investors, patient advocates and policy leaders.
CEOs — Neurotech, CellTech, BioTech, MedTech & PharmaTech
Mayors
Governors
Scientists — Cancer, Alzheimer’s Disease, Spine & Mental Health
Government Officials
Ministers
Brain Initiatives
Media
Philanthropists
AI CEOs
Investors
Nonprofits
Associations
Policy Think-Tanks
Invited Patient Advocates
Explore the N20 global initiatives and published work.
Access the N20 brain initiatives and key N20 publications, communiques and international program documents.
Global Brain Initiatives
Regional initiatives supporting international collaboration in brain health, neuroscience and neurotechnology.
N20 Publications
Selected N20 reports, scientific publications and international G20/N20 documentation.
Tentative Program* · December 13, 2026 · Miami
Location: Pullman Miami Airport Hotel, Miami, Florida. Initiatives: Middle East; Australasia; America; Europe; Latin America. Topics: Spine and Regeneration; Computational Neurotechnology; Longevity; Immunocellular Therapeutics; Neuroeconomics (Brain, Spine and Mental Wellness Economics).
The schedule, session titles, room assignments, speakers and timing are tentative and may be revised as the N20 Summit program is finalized.
| Time | Room I | Room II | Room III |
|---|---|---|---|
| 7:00 AM | Breakfast + Registration | Breakfast + Registration | Breakfast + Registration |
| 8:00 AM | 1. Opening Ceremony [Presidential Keynote] | 1. Opening Ceremony [Presidential Keynote] | 1. Opening Ceremony [Presidential Keynote] |
| 9:00 AM | Break + Press | Break + Press | Break + Press |
| 10:00 AM | 1p. Breakouts — Plenary/Panel Discussion (Global Burden of Traumatic Brain and Spine Injury and Disorders) | 1p. Breakouts — Plenary/Panel Discussion (Global Burden of Brain Cancers — Neuro-Oncology) | 1p. Breakouts — Plenary/Panel Discussion (Role of AI in Brain Mapping and Imaging) |
| 10:45 AM | Break | Break | Break |
| 11:00 AM | 2. Keynote/General Session | 2. Keynote/General Session | 2. Keynote/General Session |
| 11:20 AM | 2p. Breakouts — Plenary/Panel Discussion (BioTech and PharmaTech in NeuroTech) | 2p. Breakouts — Plenary/Panel Discussion (International Brain Initiatives) | 2p. Breakouts — Plenary/Panel Discussion (Neuro-ophthalmology and neuro-optometry) |
| 12:00 PM | 3. Keynote/General Session | 3. Keynote/General Session | 3. Keynote/General Session |
| 12:20 PM | Luncheon + Working Group / Keynote Panel | Luncheon + Working Group / Keynote Panel | Luncheon + Working Group / Keynote Panel |
| 1:20 PM | 4. Keynote/General Session | 4. Keynote/General Session | 4. Keynote/General Session |
| 1:40 PM | 3p. Breakouts — Plenary/Panel Discussion (Global Neurosurgery and Neuroscience Partnership) | 3p. Breakouts — Plenary/Panel Discussion (Global Mental Wellness) | 3p. Breakouts — Plenary/Panel Discussion (Impact of Neurotechnology on the G20 Economy) |
| 2:25 PM | Break | Break | Break |
| 2:40 PM | 5. Keynote/General Session | 5. Keynote/General Session | 5. Keynote/General Session |
| 3:00 PM | 4p. Breakouts — Plenary/Panel Discussion (AI in Neurotech Innovation) | 4p. Breakouts — Plenary/Panel Discussion (Neurodegenerative Disorders — Global cost and burden) | 4p. Breakouts — Plenary/Panel Discussion (Immuno-cellular Therapeutics and its impact on Global Burden of disease) |
| 3:45 PM | Break | Break | Break |
| 4:00 PM | 6. Keynote/General Session | 6. Keynote/General Session | 6. Keynote/General Session |
| 4:20 PM | 5p. Breakouts — Plenary/Panel Discussion (Global Burden on Pediatric Disorders) | 5p. Breakouts — Plenary/Panel Discussion (AI application and regulation in Neurotech) | 5p. Breakouts — Plenary/Panel Discussion (FinTech and Neurotech) |
| 5:05 PM | Resolution | Resolution | Resolution |
| 6:00 PM | Picture + Press | Picture + Press | Picture + Press |
| 8:00 PM | Reception Dinner (GALA) | Reception Dinner (GALA) | Reception Dinner (GALA) |
Session format: Keynotes / General Sessions (15 min) in the Ballroom; Plenary / Panel Discussions (45 min) in breakout rooms. Mandatory session: Global Partnerships and Brain Initiative. Neuroeconomics focus: Brain, Spine and Mental Wellness Economics.
Meet the N20 panelists.
Confirmed speakers and selected invited participants for the 13th Annual Neuroscience20 Summit in Miami. Mehmet Oz is listed as To Be Confirmed pending final confirmation.
Confirmed PanelistPatrick Soon-Shiong MBBCh, MSc, FRCS(C)
Physician, surgeon, scientist, inventor and healthcare entrepreneur; Chairman and CEO of NantWorks, with work spanning cancer therapeutics, biotechnology, healthcare technology and media.
To Be ConfirmedMehmet Oz MD, MBA
Administrator of the Centers for Medicare & Medicaid Services and a cardiothoracic surgeon whose work spans medicine, health policy and healthcare delivery. Status: To Be Confirmed.
Confirmed PanelistRobert J. Hariri MD, PhD
Surgeon, biomedical scientist and entrepreneur; founder and CEO of Celularity and a pioneer in cellular and regenerative medicine.
Confirmed PanelistMo Heidaran PhD
Chief Regulatory Scientist at Cellx Inc. and founder of the Cory Heidaran Charitable Foundation (CHCF), with more than 35 years of experience spanning the FDA, biotech, industry and consulting. His expertise includes cell and gene therapy development, CMC, GMP, regulatory strategy and advanced therapeutics.
Confirmed PanelistKasif Nevzat Tarhan MD
President and Rector of Üsküdar University and a leading Turkish psychiatrist and neuropsychology expert.
Confirmed PanelistAaron G. FillerMD, PhD, JD, FRCS
Medical Director of the Institute for Nerve Medicine in Santa Monica and Houston. A globally recognized neurosurgeon and specialist in peripheral nerve and spine disorders, Dr. Filler pioneered MR Neurography and advanced image-guided and minimally invasive approaches to complex nerve and spine conditions. He holds an MD from the University of Chicago, a PhD from Harvard University and is a Fellow of the Royal College of Surgeons of England.
Confirmed PanelistNagy Youssef MD, PhD
Professor and Division Director in Psychiatry and Behavioral Medicine at Michigan State University, with research in neuromodulation and genomic medicine.
Confirmed PanelistJessica Sonia Fortin DVM, PhD
Assistant Professor at Purdue University College of Veterinary Medicine and leader of the Fortin Drug Discovery Lab, focused on neurodegenerative disease therapeutics.
Confirmed PanelistKeerthy Sunder MD
Double board-certified psychiatrist and Chief Medical Officer of Karma Doctors and Karma TMS, with extensive work in neuromodulation, addiction psychiatry and PTSD research.
Confirmed PanelistDeborah Zelinsky OD
Founder and Executive Research Director of the Mind-Eye Institute and former President of SBMT, with a focus on neuro-optometric rehabilitation.
Confirmed PanelistKianor Shah DMD, MBA
Dentist, entrepreneur and healthcare technology leader working at the intersection of AI, healthcare innovation and international collaboration.
Confirmed PanelistAlexandra Talaber OD, FOVDR, FAAO
Board-certified neuro-optometrist and founder of the Neuro-Vision Therapy Institute, specializing in vision rehabilitation and post-concussion care.
Confirmed PanelistPeter Schmidt PhD
Chief Scientific Officer at Dr. Vince Clinical Research with extensive leadership across neurology, psychiatry, immunology and clinical development.
Confirmed PanelistAshraf Elsayegh MD, FCCP
Pulmonologist and critical care specialist at Cedars-Sinai Medical Center with extensive expertise in respiratory complications of neuromuscular disease.
Confirmed PanelistChristopher Boudakian DO
Medical Director and Chief of Staff at California Rehabilitation Institute, leading spinal cord injury and disorders rehabilitation.
Confirmed PanelistDenis Fedorenko MD, PhD, DSc
Professor at the A.A. Maximov Department of Hematology and Cellular Therapy, focused on autoimmune CNS disease and autologous transplantation for multiple sclerosis.
Confirmed PanelistShinichiro Akiyama MD, PhD
Director of the Tokyo Cancer and Intractable Disease Support Center and CEO of Natural Medica Japan, with research in cancer and gene-editing approaches.
Confirmed PanelistArifa Kokab M.MSc, MScEng, Exec.MBA
Biomedical neuroscientist and applied AI engineer specializing in computational neuroscience, neuromorphic AI, governed automation and neurotechnology.
Confirmed PanelistQifa Zhou PhD
Zohrab A. Kaprielian Professor in Engineering and Professor of Biomedical Engineering and Ophthalmology at the University of Southern California. A leading researcher in high-frequency ultrasound transducers, photoacoustic and multimodal biomedical imaging, Dr. Zhou is also a principal investigator at the NIH Resource Center on Medical Transducer Technology and an IEEE, SPIE and AIMBE Fellow.
Organizations supporting the N20 platform.
Current sponsor and supporting-organization entries are carried forward from the existing N20 site code, with direct links to the organizations’ websites.
Explore the N20 Sponsorship Prospectus
Review partnership opportunities, visibility, participation and sponsorship pathways.